Abernethy leaving Verily for non-profit

Amy Abernethy will depart  Verily Life Sciences LLC next year as president of product development and CMO for a role leading an undisclosed “non-profit institute focused on galvanizing government, health systems, academia, life sciences and health tech to enable a ‘learning health system’ and better accelerate evidence generation,” according to a Verily statement. 

CSO Andrew Trister will take on an expanded role as chief medical and science officer. Trister joined Verily in August from Bill & Melinda Gates Foundation, where he was deputy director of digital health and artificial intelligence. Verily also said that Chief Clinical Officer and Head of Health Equity Vindell Washington will join the company’s leadership team. The company will announce plans for the product organization early next year, according to a company spokesperson...